Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariana Genova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • B. Atanasova

    Department of Clinical Laboratory and Clinical Pharmacology, University Hospital “Alexandrovska”, Medical University – Sofia , Bulgaria

    1 shared publication
  • Bisera Atanasova

    Med Univ Sofia, Alexander Univ Hosp, Dept Clin Lab, Fac Med, 1 SvG Sofiyski Str, Sofia 1431, Bulgaria

    1 shared publication
  • Bisera Atanasova

    Department of Clinical Laboratory and Clinical Immunology, Medical University, Sofia, Bulgaria

    1 shared publication
  • Bisera Dimitrova Atanasova

    1 shared publication
  • D. Svinarov

    Department of Clinical Laboratory and Clinical Pharmacology, University Hospital “Alexandrovska”, Medical University – Sofia , Bulgaria

    1 shared publication
  • Emilia Naseva

    Med Univ Sofia, Fac Publ Hlth Prof Tsekomir Vodenicharov MD DSc, Dept Hlth Econ, Sofia, Bulgaria

    1 shared publication

Latest Publications

  • Open Access

    Association Between Zinc Status and Insulin Resistance/Sensitivity Check Indexes in Gestational Diabetes Mellitus

    by Mariana P. Genova, Irena Ivanova, Emilia Naseva, Bisera Atanasova

    Gestational diabetes mellitus (GDM) is considered the most common metabolic disorder of the pregnancy period. It is characterized by pancreatic beta-cell dysfunction in the setting of chronic insulin resistance. Zinc is a nutrient involved in numerous metabolic processes and shows a relationship with glycometabolic disorders and GDM. The latest data have demonstrated the association of zinc with insulin sensitivity and resistance. The exact role of zinc in the connection with indexes of insulin resistance and insulin sensitivity is still not fully clarified. The aim of the study is to analyze the newly calculated indexes Glu/Zn, Ins/Zn, and HOMA-IR/Zn as surrogate markers to explore the correlation between serum zinc status and some indexes of insulin sensitivity and insulin resistance. The possible role of these indexes as markers of insulin resistance in pregnant women was analyzed too. An ROC analysis demonstrated that HOMA-IR/Zn with AUC 0.989, p < 0.001 (95% CI 0.967–1.000) and Ins/Zn with AUC 0.947, p < 0.001 (95% CI 0.889–1.000) in the GDM group, and only HOMA-IR/Zn index with AUC 0.953, p < 0.001 (95% CI 0.877–1.000) in healthy pregnant women, have good power as markers of insulin resistance in both groups. We speculate that these new ratios could be suitable for the assessment of pregnant women at high risk of insulin resistance development and, probably, for the evaluation of the specific pathophysiologic characteristics of women with GDM.


  • Maternal Serum Copper and Some Metabolic Indexes in Late Second Trimester of Gestational Diabetes Mellitus Pregnancy

    by Mariana Genova, Irena Ivanova, Emilia Naseva, Milena Velizarova, Bisera Atanasova

    Background: Copper (Cu) is a physiologically important trace element during pregnancy. The study aim is to assess the altered level of serum Cu and its association with some metabolic indexes in Gestational Diabetes Mellitus (GDM). Methods: A total of 108 pregnant women (aged 18-40, second trimester) are included in the study and divided into two groups (GDM n = 54; pregnant with normal glucose tolerance (NGT), n = 54) after performing a 2-hour 75-g oral glucose tolerance test (OGTT). Maternal blood samples are collected at 26-28 gestational week. All biochemical parameters are measured in serum from fasting venous blood. Serum Cu levels are analyzed by flame atomic absorption spectrophotometry (Perkin Elmer AAnalyst 300, USA). Body Mass Index (BMI), insulin sensi-tivity/resistance, triglyceride-glucose (TyG), TyG-BMI (triglyceride glucose-body mass) indexes are calculated by formulas. Results: The following data were observed: significantly higher levels of serum Cu (p = 0.009), pre-pregnancy BMI (pre-pBMI), BMI at the GDM diagnosis (pBMI), TyG, pregnancy TyG-BMI (pTyG-BMI) p < 0.001, and triglycer-ides (Tgl) (p = 0.02) in GDM compared to NGT pregnancy. The study presents a positive correlation between serum Cu and pre-pBMI (p < 0.02), pBMI and pTyG-BMI (p < 0.001). Besides, pre-pBMI (mean >= 25 kg/m 2), pBMI (mean >= 30 kg/m 2), and pTyG-BMI are associated with 14.5% (OR 1.145, 95% CI: 1.064-1.232; p < 0.001), 15.3% (OR 1.153, 95% CI: 1.070-1.243; p < 0.001), and 5.9% (OR 1.059, 95% CI: 1.022-1.086; p < 0.001) increased risk for GDM development. No association is found between Cu and Tgl levels, fasting plasma glucose e(FPG) and TyG. ROC analysis suggests the serum Cu as a possible risk factor for GDM development. The analysis shows that at a cutoff point of >= 31.9 mu mol/L, serum Cu presents a sensitivity and specificity of 64.8% and 66.7% in the prediction of GDM development (AUC = 0.659, p < 0.012). After adjustment for maternal age, gestational age, and family predisposition, the odds ratios (ORs) (95% CIs) still show association of Cu levels with increased GDM risk (OR 1.099, 95% CI 1.018-1.184, p = 0.013). Conclusions: pTyG-BMI index exhibits a better interaction than TyG index, Tgl, and glucose separately with serum Cu levels where BMI has a mediator's role.


  • Open Access

    Body Mass Index and Insulin Sensitivity/Resistance: Cross Talks in Gestational Diabetes, Normal Pregnancy and Beyond

    by Mariana Petrova Genova, Bisera Dimitrova Atanasova, Katya Nikolova Todorova-Ananieva

    Pregnancy is a complex of metabolic, physiological, biochemical, and immunological changes in women’s body, usually reversible after delivery in normal pregnancy. Gestational diabetes mellitus (GDM) is defined as “any degree of glucose intolerance with onset or first recognition during the current pregnancy.” The etiology of the GDM is multifactorial and not sufficiently elucidated. The overweight and obesity during prepregnancy and pregnancy are one of the main modifiable risk factors of GDM. Maternal obesity increases the risk of a number of pregnancy complications, adverse pregnancy outcome for mother and child, and related chronic conditions in women. The obesity prevalence is the greatest among children of obese mothers, and an independent association between maternal body mass index and offspring adiposity and insulin resistance exists. Although the underlying mechanism remains unclear, available evidence suggests that GDM pathogenesis is based on relatively diminished insulin secretion coupled with pregnancy-induced insulin resistance. Recent findings provide data that higher BMI leads to decreased insulin sensitivity and higher degree of insulin resistance and contributes to GDM development.


  • Open Access

    Trace Elements and Vitamin D in Gestational Diabetes

    by Mariana Genova, B. Atanasova, I. Ivanova, K. Todorova, D. Svinarov

    Gestational diabetes mellitus (GDM), one of the most common pregnancy complications, is defined as glucose intolerance with onset or first recognition during pregnancy. Its prevalence varies worldwide in dependence on characteristics of the underlying population and applied diagnostic criteria. The etiology is multifactorial and not sufficiently elucidated. Available evidence suggests that the base of pathogenesis is relatively diminished insulin secretion coupled with pregnancy-induced insulin resistance. Modifiable and non-modifiable risk factors for development have been identified. Trace elements and vitamin D could be contributed to modifiable factors for prediction the risk in a large population. Essential trace elements in pregnancy are necessary to overcome systemic oxidative, metabolic and inflammatory stress. Evidence, still inconclusive, has been accumulated about the relation between higher incidence of vitamin D failure/deficiency during pregnancy and GDM. The lower level of 25-OH vitamin D could be associated with increased risk for anemia development, also including pregnant women. This review intends to provide an overview of the possible link between both vitamin D and trace elements as risk factors for GDM development.